LEIDY CARABALLO GALVA

Concepts (20)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
920
0.780
Why?
Liver Neoplasms
2
2021
1292
0.700
Why?
Immunotherapy
1
2020
675
0.470
Why?
Immunotherapy, Adoptive
1
2020
816
0.420
Why?
Glypicans
1
2021
35
0.190
Why?
T-Lymphocytes
2
2020
1718
0.180
Why?
alpha-Fetoproteins
1
2020
132
0.160
Why?
Xenograft Model Antitumor Assays
1
2021
884
0.150
Why?
Cancer Vaccines
1
2020
176
0.150
Why?
Receptors, Antigen, T-Cell
1
2020
476
0.130
Why?
Antibodies, Monoclonal
1
2021
1034
0.130
Why?
Mice
2
2021
17646
0.070
Why?
Animals
2
2021
34246
0.050
Why?
Humans
3
2021
125040
0.040
Why?
HLA-A2 Antigen
1
2020
26
0.040
Why?
Pyrophosphatases
1
2020
21
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
65
0.040
Why?
Cross Reactions
1
2020
192
0.040
Why?
Lymphocyte Activation
1
2020
697
0.040
Why?
Cells, Cultured
1
2020
3054
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (20)
Explore
_
Similar People (59)
Explore
_